Metastatic Non-Small Cell Lung Cancer Recruiting Phase 0 Trials for Pembrolizumab (DB09037)

Also known as: Metastatic untreated non small cell lung cancer / Non-Small Cell Lung Cancer Metastatic / Metastatic Non-small Cell Lung Cancer (NSCLC) / Metastatic Non-Small-Cell Lung Cancer / Lung cancer non-small cell stage IV / Non-small cell lung cancer stage IV

DBCOND0043377 (Metastatic Non-Small Cell Lung Cancer)Recruiting0 IdentifierTitlePurposeDrugs
NCT03224871UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.Treatment